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Background: Non-tuberculous mycobacteria (NTM) are increasingly important as opportunistic infections after
major and minor surgical procedures, likely because they are ubiquitous and not effectively killed by many com-
monly used disinfectants. Outbreaks of soft tissue infections with NTM appeared related to the use of commer-
cial disinfectants based on quaternary ammonium compounds (QACs).
Methods: We studied the survival of clinical and environmental isolates of Mycobacterium abscessus, Mycobac-
terium massiliense, Mycobacterium chelonae and Mycobacterium fortuitum after 20 min, 60 min or 24 h
exposures to different QACs, and the surviving bacteria were then re-exposed to QACs to see if the percentage
of surviving bacteria had increased. The bacteria were labelled with a dnaA–gfp fusion and their level of QAC
resistance monitored as increasing ﬂuorescence. The QAC-resistant bacteria were then serially restreaked onto
non-selective medium and retested for QAC survival.
Results: The frequency of survivors was ,1i n1 0
5 bacteria with Mycobacterium smegmatis, but .1 in 100 with
the other mycobacteria studied. Different environmental and clinical isolates had similar QAC MICs, but QAC
survivors of each strain were resistant. The QAC-surviving strains reverted to the original, non-resistant pheno-
type after several passages on non-selective medium.
Conclusions: QACs should not be used in settings where even minimally invasive procedures are performed,
as they select for a non-genetically determined reversible resistant phenotype that appears at high frequency
with several rapidly growing mycobacterial species associated with healthcare-related infections. M. smegmatis
behaves differently and is not an adequate model for testing the activity of disinfectants against NTM.
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Introduction
The recent popularity of conventional and non-conventional cos-
metic procedures, often performed by diverse practitioners in
less than optimal settings, has been associated with outbreaks
of non-tuberculous mycobacteria (NTM) infections of the skin
and soft tissues.
1–3 Infections with the Mycobacterium absces-
sus–chelonae group and Mycobacterium fortuitum are among
the most common and most difﬁcult to treat.
4 While some of
these cases were associated with the injection of contaminated
local anaesthetics and mixtures purported to reduce adiposity,
many cases were apparently related to the use of surgical instru-
ments that were inadequately sterilized or incomplete
disinfection of the skin prior to the procedure.
5 Some outbreaks
appeared to be associated with the use of disinfectants whose
active ingredient is a quaternary ammonium compound (QAC),
a class of disinfectants regarded as having only mycobacterio-
static activity.
6 In order to explain more precisely how the use
of a disinfectant might be associated with infections,
7 we inves-
tigated the activity of QACs against several species of NTM.
Materials and methods
Bacterial strains and plasmids
Mycobacterium smegmatis mc
2155 and Mycobacterium bovis BCG are
strains commonly used in the laboratory (Laboratorio de Gene ´tica
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2574Molecular, IVIC). Mycobacterium terrae was obtained from the ATCC (ATCC
15755). The other mycobacterial strains were isolated in Caracas (Lab. TB,
Inst. Biomedicina) from patient material or environmental sources
(Table 1). The PRA method was used for initial strain identiﬁcation (poly-
merase chain reaction–restriction enzyme analysis) (http://
app.chuv.ch/prasite/index.html), but deﬁnitive species assignment
was obtained by sequencing a fragment of the rpoB gene ampliﬁed
with primers MycoF (5′-GGCAAGGTCACCCCGAAGGG-3′) and MycoR
(5′-AGCGGCTGCTGGGTGATCATC-3′).
8
Resistant survivors and revertants were obtained as noted in
Table 1. The strains were grown at 378C in Middlebrook 7H9 liquid
medium supplemented with 10% OAD (oleic acid, albumin, dextrose),
0.2% glycerol and 0.05% Tween 80 (7H9-OAD-Tw) or on Petri dishes con-
taining Middlebrook 7H10 supplemented with 10% OAD and 0.2% gly-
cerol. Plasmids pFPV27
9 and pYUB412
10 were gifts from Dr Lalita
Ramakrishnan (University of Washington, Seattle, WA, USA) and Drs
Martin Pavelka (University of Rochester, NY, USA) and William R. Jacobs
Jr (Albert Einstein College of Medicine, Bronx, NY, USA), respectively.
Disinfectants
The disinfectants evaluated were: hexadecyl trimethyl ammonium
bromide (centrimonium bromide; C19H42NBr; CTAB); dodecyl trimethyl
ammonium bromide (C15H34NBr; DTAB); cetylpyridinium chloride
(C21H38NCl; CPC); tetradecyl trimethyl ammonium bromide (C17H38NBr;
TTAB); and dimethyl benzyl lauryl ammonium bromide [C13H27NBr;
DBLAB, marketed under a commercial product name (http://www.
pharmcast.com/Patents/Yr2002/August2002/082702/6441045_Disinfectant
082702.htm)]. The disinfectants were prepared by dissolving CTAB, CPC,
DTAB and TTAB in 50 mL volumes of 7H9-OAD-Tw to obtain 4% or 10%
solutions of each. For the marketed disinfectant, the 10% commercial
product solution was used directly in some studies or diluted to 4% in
7H9-OAD-Tw as the starting concentration in the 96-well plate assay.
All disinfectant solutions were kept at 48C until used. The highest concen-
trations tested were 9%, made up of 9 parts of the 10% solution and one
part of bacterial inoculum.
Determination of mycobactericidal activity and selection
of resistant survivors
The mycobacterial strains were grown in 50 mL tubes to an OD600 of 1.0
( 10
9 cfu/mL). Ten 1.0 mm glass beads were added and the tube was
vortexed for 20 s and then left to stand for 10 min to allow for clumps
to sediment. When necessary, the resulting suspension was diluted seri-
ally, 1:10, in 7H9. An aliquot of 1 mL of the ﬁnal suspension was then
added to 9 mL of 10% DBLAB (the undiluted commercial preparation)
or 10% CTAB and left to incubate with agitation for 20 min, 1 h or
24 h. Subsequently, after vortexing for 1 min, 1 mL of the disinfectant
containing bacterial suspension was added to 9 mL of neutralizing sol-
ution (10% Tween 80, 0.5% sodium thiosulphate, 0.1% histidine in
0.25 M phosphate buffer, pH 7.0), which was then centrifuged at
3000 rpm for 10 min. The supernatant was discarded and the pellet
resuspended in  300 mL of the residual medium. Three  100 mL aliquots
of this pellet were then spread onto three 7H10 OAD plates without
detergent and incubated at 378C for 4–8 days, at which point surviving
colonies were counted. Assays were performed in triplicate. Controls
were treated identically, but incubated without disinfectant.
The selection for glutaraldehyde-resistant colonies was slightly differ-
ent. After vortexing and allowing for clumps to settle, as above, the resul-
tant supernatant was then transferred to a new 50 mL tube that was
placed into a bath sonicator for 5 min. An aliquot of 100 mLof this suspen-
sion was added to 900 mL of 2% glutaraldehyde. After 5, 20 and 60 min,
Table 1. Strains used in this study: mycobacterial isolates, their resistant derivatives selected after
exposure to the indicated disinfectants and revertants obtained by restreaking the resistant strains
on medium without disinfectant
Strain Origin
M. massiliense WT 1.0 M. massiliense clinical isolate LTE3550
M. massiliense 1.2 M. massiliense WT 1.0 selected in 9% CTAB
M. abscessus WT 2.0 M. abscessus clinical isolate LTE3514
M. abscessus 2.1 M. abscessus WT 2.0 selected in 9% CTAB
M. abscessus 2.1.3 M. abscessus 2.1 restreaked 3 times
M. abscessus 2.1.6 M. abscessus 2.1 restreaked 6 times
M. abscessus 2.2 M. abscessus WT 2.0 selected in 9% DBLAB
M. abscessus 2.2.3 M. abscessus 2.2 restreaked 3 times
M. abscessus 2.2.6 M. abscessus 2.2 restreaked 6 times
M. abscessus 2.3 M. abscessus WT 2.0 selected in glutaraldehyde 2% for 5 min
M. abscessus 2.3.3 M. abscessus 2.3 restreaked 3 times
M. abscessus 2.3.6 M. abscessus 2.3 restreaked 6 times
M. fortuitum WT 1.0 M. fortuitum clinical isolate LTE1428
M. fortuitum 1.2 M. fortuitum WT 1.0 selected in 9% DBLAB
M. chelonae WT 2.0 M. chelonae clinical isolate LTE2714
M. chelonae 2.1 M. chelonae WT 2.0 selected in 9% CTAB
M. chelonae 2.2 M. chelonae WT 2.0 selected in 9% DBLAB
M. fortuitum WT 3.0 M. fortuitum environmental isolate LTE2297
M. fortuitum 3.2 M. fortuitum WT 3.0 selected in 9% DBLAB
M. terrae ATCC 15755
M. smegmatis mc
2155 laboratory strain (Laboratorio de Gene ´tica Molecular, IVIC)
M. bovis BCG laboratory strain (Laboratorio de Gene ´tica Molecular, IVIC)
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JAC100 mL of the glutaraldehyde suspension was added to 900 mL of neutra-
lizing solution (6% Tween 80, 1% sodium thiosulphate, 0.5% sodium thio-
glycolate and 0.15% cysteine). From the neutralized suspension, three
100 mLaliquots were plated onto 7H10 plates without OAD and incubated
at378Cfor4–8 days,whensurvivingcolonieswerecounted.Negativecon-
trols were performed with sterile water in place of glutaraldehyde.
Cloning of the dnaA–gfp fusion
Reagents for DNA manipulations were obtained from commercial sources
and used according to routine protocols. For the construction of plasmid
pdnaA–gfp, the dnaA promoter region from M. tuberculosis (582 bp) was
ampliﬁed from a cosmid
11 containing the rpmH–dnaA region, using
primers GLRA3 (5′-CTA TGT CTG GCA ACA T) and GLRA4 (5′-TAT CTC CCT
GGT TCT CGT TA), and ligated into the BamHI and EcoRV sites upstream
of gfp on plasmid pFPV27. The chromosomal integrating version of the
dnaA–gfp fusion, on plasmid pintdnaA–gfp, was obtained by cloning a
BamHI–BclI fragment from pdnaA–gfp into the BclI site of pYUB412.
10
Plasmids pdnaA–gfp and pintdnaA–gfp were electroporated into the
mycobacterial strains and plated onto medium containing kanamycin
(pdnaA–gfp) or hygromycin (pintdnaA–gfp). GFP-expressing mycobac-
teria were visualized for ﬂuorescence using a Nikon Eclipse 600 ﬂuor-
escence microscope.
Monitoring bacterial growth by ﬂuorescence
A colony of mycobacteria from solid medium was inoculated into 5 mL of
7H9-OAD-Tw (with kanamycin when the strains contained plasmid
pdnaA–gfp or hygromycin for strains with integrating plasmid pintd-
naA–gfp) in a 50 mL conical tube and grown with agitation at 378C
until reaching exponential phase. The colony was then transferred to
50 mL of the same medium and grown in 500 mL ﬂasks. For the initial
studies comparing ﬂuorescence versus growth, samples were taken
periodically to measure the optical density (OD) and ﬂuorescence:
every 3 h for M. smegmatis; every 6 h for M. abscessus; and every 24 h
for M. chelonae. OD600 was measured in a 96-well spectrophotometer
(Molecular Devices SpectraMax 340) and ﬂuorescence (485 nm excitation
and 535 nm emission) was measured in a 96-well plate ﬂuorimeter (Mol-
ecular Devices SpectraMax, GeminisXS).
Assay of disinfectant activity using ﬂuorescent
mycobacteria
The different bacteria were grown in 50 mL tubes to an OD600 of 1.0
( 10
9 cfu/mL). Then, 5 mL of each was transferred to a new 50 mL
conical tube, 10 glass beads (1.0 mm) were added, and the tube was vor-
texed for 20 s and left to stand for 10 min to allow for clumps to sedi-
ment. An aliquot of 100 mL of the suspension was added to 9.9 mL of
7H9-OAD-TW and, then, 1 mL of this was added to 9 mL of the same
medium, which was then mixed and used as the inoculum in the
96-well plate assay. For some assays, a second 1:10 dilution in
medium was performed, so that 10
5 or 10
4 bacteria, in 100 mL, were
added to each well.
The assay was performed using black 96-well plates, one disinfectant
per plate. An aliquot of 200 mL of the highest concentration of the disin-
fectant to be tested was placed into the ﬁrst column and 100 mLo f
7H9-OAD-Tw was added to the other columns. Using a multichannel
pipette, 100 mL from the wells with the highest disinfectant concen-
tration was diluted into the 100 mL of 7H9-OAD-Tw in the next column,
and the dilution process serially repeated to obtain ﬁnal concentrations
of 4%, 2%, 1%, 0.5%, 0.25%, 0.125% and 0.06%. Each concentration
was evaluated in triplicate. An aliquot of 100 mL of the mycobacterial
suspension was added into each well, and positive controls without dis-
infectants and negative controls with medium alone were included on
each plate. Peripheral wells were ﬁlled with 200 mL of sterile distilled
water. The plates were incubated with agitation at 378C and the ﬂuor-
escence read periodically over 4 days in a Molecular Dynamics Spectra-
max GeminisXS Fluorimeter/Luminometer.
Results
QACs kill most mycobacteria, but survivors appear at
high frequencies in M. chelonae and M. abscessus
Although the QAC disinfectants are cidal for most bacteria, they
have been generally regarded as only mycobacteriostatic. To test
this, M. smegmatis, M. chelonae and M. abscessus were exposed
to CTAB or to a commercial disinfectant commonly used in Vene-
zuela, which will be referred to as DBLAB, for dimethyl benzyl
lauryl ammonium bromide (C13H27NBr), its active QAC ingredient.
Both CTAB and DBLAB were used as 9% concentrations, close to
the 10% commercial presentation of DBLAB.
The mycobacteriawere exposed to the QACs for 20 min, 60 min
or 24 h, after which the QACs were neutralized and the mycobac-
teria plated on non-selective medium. After 20 or 60 min
exposures, both QACs appeared to effectively kill M. smegmatis,
with resistant colonies appearing at a frequency of ,1i n1 0
5
(Table 2). The disinfectants also appeared to kill most M. abscessus
and M. chelonae, but surviving colonies appeared at frequencies
of .5 in 100 after 20 and 60 min exposures, with lower fre-
quencies of survival after a 24 h exposure.
The surviving colonies were then selected, grown in liquid
medium without QACs and again subjected to 20 min, 60 min
or 24 h exposures to 9% CTAB or 9% DBLAB. The survival rates
were now ≥ 50% after 20 and 60 min exposures to both
agents, but remained at ,1 in 100 after 24 h exposures
(Table 2). This was true even for those strains obtained from
colonies surviving a 24 h exposure. Strains obtained from colo-
nies surviving a 5 min or 20 min exposure to 2% glutaraldehyde
behaved similarly, but were only minimally more resistant to glu-
taraldehyde than the parent strain. No survivors were obtained
with longer exposures to 2% glutaraldehyde.
Equivalent results were obtained when the experiment was
repeated with clinical or environmental isolates of M. massiliense
and M. fortuitum. Some of these original, parental isolates dis-
played the rough colony morphotype, while others had smooth
colonies. The original colony morphotype tended to persist in
the QAC surviving colonies, but some smooth QAC surviving
strains began to produce a minority of rough colonies when
restreaked. Smooth strains showed greater motility (data not
shown), but neither motility nor colony morphotype appeared
to be correlated with QAC resistance.
Susceptibility to QACs determined by ﬂuorescence
To assess QAC susceptibility in another format, the mycobacteria
were labelled with a dnaA–gfp fusion, which permitted bacterial
growth to be monitored as ﬂuorescence in a 96-well plate assay
(Figure S1, available as Supplementary data at JAC Online). Using
this method, clinical and environmental isolates of M. abscessus
and M. massiliense were less susceptible to DBLAB than
M. chelonae and M. fortuitum, but the strains grown from
colonies surviving exposure to DBLAB and CTAB were resistant
to all concentrations tested (Figure 1).
Cortesia et al.
2576To learn more about the innate susceptibility of different
mycobacteria to QACs, we compared the growth of M. smegma-
tis, M. chelonae, M. abscessus, M. bovis BCG and M. terrae in the
presence of increasing concentrations of CTAB, DBLAB and
three other QACs (Figure S2, available as Supplementary data
at JAC Online). The susceptibilities varied somewhat with the
different QACs, but M. abscessus tended to be the most resistant
and M. smegmatis the most susceptible. Notably though, the
susceptibility of M. smegmatis to DBLAB was very similar to
that of M. chelonae and M. fortuitum (Figure 1b).
Reversibility of QAC resistance
The very high frequency of QAC-resistant survivors of M. absces-
sus, M. massiliense, M. chelonae and M. fortuitum seemed
inconsistent with a genetic alteration, so we tested whether
the resistant phenotype was reversible. Three M. abscessus sur-
vivor strains, derived from the same parent strain after
exposure to CTAB (2.1), DBLAB (2.2) or a 5 min exposure to glu-
taraldehyde (2.3), were serially restreaked to non-selective
medium. After three and six passages, they were again sub-
jected to 20 or 60 min exposures to CTAB and DBLAB. After
three passages, the survival of all three strains had fallen to
 30% and after six passages only  5% of the plated bacteria
survived, similar to the original parent strain (Figure 2). Resist-
ant M. chelonae survivor strains showed similar reductions in
QAC survival after serial restreaking on non-selective medium
(data not shown).
Discussion
Provoked by the occurrence of NTM infections that appeared to
be associated with the use of commercial QAC disinfectants,
12,13
we investigated the effectiveness of QACs against mycobacteria.
QACs are described in the literature as only mycobacteriostatic,
so we were surprised to ﬁnd that a 20 min exposure to QACs
appeared to be cidal against M. smegmatis, with at least 5 logs
of killing;
14 although their effectiveness would likely be less if
assayed in a carrier test in the presence of organic material.
15
Against M. fortuitum, M. chelonae, M. massiliense and M. absces-
sus, however, even with the simple suspension test employed
here, we found that QACs kill only  90%–95% of bacteria. This
suggests that the use of QACs will not prevent, and may even
promote, the occurrence of infections with M. fortuitum and
the M. chelonae–abscessus group of NTM.
From these results, the QACs cannot accurately be called
mycobacteriostatic, because when the agent is removed, the
majority of the bacteria are not viable. Neither can they be
termed effectively mycobactericidal, at least for M. fortuitum
and the M. chelonae–abscessus group, because there are
,2 logs of killing after 1 h of exposure. This high percentage of
survival has been previously reported,
14,15 but the nature of the
survivors apparently was not investigated. It is not clear why
this high frequency of persisters is not seen with M. smegmatis,
but it cannot simply depend upon the level of innate resistance,
as some of the original parental M. fortuitum and M. chelonae
isolates were as susceptible to DBLAB as was M. smegmatis
(Figure 1b).
Table 2. The number of colonies of different strains surviving exposures to CTMB, DBLAB or glutaraldehyde
M. abscessus M. chelonae M. smegmatis
Exposure
2.0 WT
 10
2 cfu
plated
2.1
Select.
CTAB
 10
2 cfu
plated
2.2
Select.
DBLAB
 10
2 cfu
plated
2.3
Select.
GTA
 10
2 cfu
plated
2.0 WT
 10
5 cfu
plated
2.3
Select.
GTA
 10
5 cfu
plated
2.0 WT
 10
2 cfu
plated
2.1
Select.
CTAB
 10
2 cfu
plated
2.2
Select.
DBLAB
 10
2 cfu
plated
2.0 WT
 10
5 cfu
plated
mc
2155 WT
 10
5 cfu
plated
5 min
2% GTA 0 0 0 0 1 4 0 0 0 2 0
20 min
9% CTAB 12 72 61 78 NT NT 14 86 76 NT 0
9% DBLAB 15 68 58 92 NT NT 4 NT NT NT 0
2% GTA 0 0 0 0 1 2 0 NT NT 0 0
60 min
9% CTAB 6 47 57 52 NT NT 8 53 73 NT 0
9% DBLAB 6 63 48 70 NT NT 3 NT NT NT 0
2% GTA 0 0 0 0 0 0 0 NT NT 0 0
24 h
9% CTAB 1 0 0 0 NT NT 0 0 0 NT 0
9% DBLAB 0 0 1 0 NT NT 0 0 0 NT 0
The strains tested were the parental isolates and their resistant derivatives, selected as survivors of previous exposures to the indicated disinfectants.
NT, not tested; GTA, glutaraldehyde; Select., the strain was selected as a survivor after exposure to the indicated disinfectant.
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JACThe QAC survivors of M. fortuitum and the M. chelonae–
abscessus group appeared at frequencies between 1% and
10%, which seems too high to be caused by genomic mutations.
Although these survivors showed QAC resistance, when they
were serially restreaked in the absence of QACs, the frequency
of QAC survivors returned to that of the original strains. This
reversible resistance, although it persists for several generations,
suggests a phenotype dependent upon non-genetic changes in
gene expression. After a 5 min or 20 min exposure to 2% gluta-
raldehyde, there also appeared, at a lower frequency,
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Figure 1. Different isolates of the M. abscessus-chelonae group and M. fortuitum show similar susceptibilities to DBLAB, while their derivatives, selected
after surviving a previous exposure, are resistant to at least 2% DBLAB. The strains were labelled with plasmid pdnaA–gfp and grown in 96-well plates
in medium containing DBLAB at the indicated concentrations. Mycobacterial growth was measured as ﬂuorescence after 4 days of incubation at 378C.
All results are from representative experiments that were repeated at least three times. (a) Comparison of the growth in DBLAB of M. massiliense
(M. mass. WT 1), M. abscessus (M. absc. WT 2), derivatives of each that were selected as survivors of a previous exposure of DBLAB (M. mass. 1.2
and M. absc. 2.2), M. smegmatis and M. chelonae. (b) Comparison of the growth in DBLAB of M. chelonae (M. chel. WT 2), two isolates of
M. fortuitum (M. fort. WT 1 and M. fort. WT 2), derivatives of each that were selected as survivors of a previous exposure to DBLAB (M. fort. 1.2,
M. chel. 2.2, and M. fort. 3.2), M. smegmatis and M. abscessus.
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2578glutaraldehyde-tolerant survivors that showed only minimally
increased resistance to glutaraldehyde, but had 60% QAC survi-
val, suggesting that they had also acquired the QAC-resistant
phenotype. This phenotype could therefore reﬂect some sort of
general stress or global resistance response.
16,17 Escherichia coli
tolerant to QACs have been described, but were selected by
adaptation to serially increasing concentrations of the disinfec-
tant,
18 much different from the one-step selection in high QAC
concentrations described here.
The QAC resistance seen in the survivors is not complete, as
there was no meaningful increase in survival after 24 h
exposures to the QACs. The M. abscessus and M. chelonae bac-
teria that survived 24 h exposures to QACs appear to represent
a second, additional form of QAC persisters. While they survive
a 1 h exposure to QACs, they are no more resistant to a 24 h
QAC exposure than the parent strains, which is similar to the pre-
viously described antibiotic persistence of non-replicating bac-
teria.
19,20 However, the frequency of the 24 h survivors seen
here ( 1/100–1/1000) is higher than has been reported for non-
replicating persisters and suggests that mycobacteria could
perhaps survive in QAC disinfectant stocks.
Like many other NTM, the M. chelonae–abscessus group have
been observed in two morphotypes, smooth and rough. While
the rough morphotype is more virulent in pulmonary infection
models,
21 the smooth morphotype has a higher production of
glycopeptidolipids
22,23 that is thought to cause their increased
motility and the increased bioﬁlm formation that has been
associated with decreased drug susceptibility.
24 We found no
association of QAC resistance and colony morphotype, as
QAC-resistant strains were selected from both rough and
smooth isolates, and tended to maintain their morphotype
(data not shown).
M. abscessus and M. massiliense belong to a family of closely
related mycobacteria.
25 They are among the NTM most com-
monly isolated from healthcare-associated skin and soft-tissue
infections,
26 although M. chelonae is closely related and also
frequently encountered. M. fortuitum is more phylogenetically
distant, but is also found in healthcare-related infections. The
dramatic recent increase in articles describing human infec-
tions with NTM, especially with the M. abscessus family,
suggests that their incidence is increasing, and M. abscessus
may have greater pathogenic capacity than other NTM.
27 The
innocuous M. smegmatis would seem an inadequate model
to study the effectiveness of disinfectants against
mycobacteria.
We are currently investigating possible mechanisms for
the QAC-resistant phenotype, such as decreased cell wall
permeability
28 or the extrusion of the QACs
7,29,30 by efﬂux
pumps,
31 similar to LfrA
32 or Tap.
33 However, while the molecular
mechanisms responsible for the resistant phenotype may yield
insights into the pathogenic potential of these bacteria, the
principal conclusion from this work is that QAC disinfectants
are insufﬁcient to prevent, and may actually promote,
healthcare-associated infections with M. fortuitum and the
M. abscessus–chelonae group of NTM.
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